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Background: Podocyte detachment and apoptosis are two risk factors causing podocyte loss, F-actin rearrangement
is involved in detachment and apoptosis. However, the nature of events that promote detachment and apoptosis of
podocytes and whether detachment occurred simultaneously with apoptosis are still unclear. Previously, it was found
that angiopoietin-like3 (Angptl3) induces F-actin rearrangement in podocytes. In this study we investigate whether
Angptl3 influences podocyte loss (detachment and apoptosis) and the process through which Angptl3 exactly
influenced the podocyte loss.
Methods: In conditionally immortalized mice podocytes, recombinant mice Angptl3 protein (rm-Angptl3) was
used to mimic Angptl3 overexpression model and transfection with small interfering RNA (siRNA) to knockdown
the expression of Angptl3. Both flow cytometry analysis and terminal deoxynucleotidyl transferase-mediated dUTP
nick-end labeling assay were used to detect apoptosis. Rearrangement of F-actin was assessed using confocal
microscopy. Western blot assay was used to measure levels of Angptl3, integrin α3β1, integrin-linked kinase (ILK),
p53, caspase 3, and phosphorylation of integrin β1.
Results: In a puromycin aminonucleoside (PAN)-induced podocyte injury model, rm-Angptl3 accelerated the loss
of podocytes, both detachment and apoptosis occurred, and F-actin rearrangement is involved in the process.
However, knockdown of Angptl3 by siRNA markedly ameliorated these injuries. Observed effects were partially
correlated with the altered integrin α3β1, ILK and p53, rather than caspase 3.
Conclusions: Angptl3 is a novel factor involved in the PAN-induced podocyte loss by affecting detachment and
apoptosis in vitro. This study helps to deepen the understanding of the mechanisms of podocyte loss and lays the
foundation for developing a new successful therapy for podocyte injury via lower expression of Angptl3.
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Podocytes are terminally differentiated and highly spe-
cialized cells that reside on the glomerular basement
membrane (GBM). As crucial components of the glom-
erular filtration barrier, podocytes play a key role in the
pathogenesis of glomerular diseases [1]. Due to limited
podocytic proliferative capacity, it has been suggested
that podocytes that are lost cannot be effectively re-
placed, causing damage to glomerular filtration barrier,* Correspondence: hxu@shmu.edu.cn
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unless otherwise stated.development of proteinuria and progressive loss of renal
function [2-5].
Angiopoietin-like-3 (Angptl3), a secreted protein, is
mainly expressed in hepatocytes and weakly expressed in
normal kidney cells [6]. Our previous study found that
the expression of Angptl3 was upregulated in nephrotic
syndrome kidney tissue, and altered expression of Angptl3
in the glomerulus was associated with proteinuria and foot
process effacement in kidney diseases [7,8]. Moreover, it
was confirmed that following treatment with adriamycin
or puromycin aminonucleoside (PAN), the expression
of Angptl3 in podocytes was especially upregulated,
and Angptl3 was involved in podocyte injury, Angptl3s is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Sequences for all the siRNAs
Sequence
siRNAs Control siRNA sense UUC UCC GAA CGU GUC AVG UTT
antisense ACG UGA CAC GUU CGG AGA ATT
Angptl3 siRNA sense GGG UCA UGG ACU UAA AGA UTT
antisense AUC UUU AAG UCC AUG ACC CTT
siRNA, small interfering RNA.
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the PAN-induced detachment of podocytes [9,10]. Re-
cently, it was further confirmed that Angptl3 induces
F-actin rearrangement [11]. Podocyte loss is caused by
detachment of cells from the GBM and/or by apoptosis
(programmed cell death) [12]. Seminal studies have shown
that podocyte cytoskeletal disaggregation preceded, and
detachment from the GBM occurred in the PAN model;
actin filament played a role in the regulation of cellular
apoptosis, and disruption of F-actin could lead to in-
creased levels of apoptosis [13,14]. Whether Angptl3
influences podocyte loss by affecting detachment and
apoptosis is a crucial question that warrants further
study.
Podocytes adhere to the GBM principally via integrin
α3β1, which is believed to be a major receptor for extra-
cellular matrix components of the GBM [15]. Studies
have reported that lower expression of integrin α3β1 in
podocytes is found in a range of glomerular disorders in
humans, and in a variety of experimental animal models
of renal disease [16]. Integrin-linked kinase (ILK) plays a
key role in integrin-mediated cell adhesion and signaling
[17]. Overexpression of ILK in podocytes might reduce
matrix adhesion and induce detachment of podocytes [18].
Both the tumor suppressor protein p53 and caspases
are involved in the crucial processes of renal and nonre-
nal cell apoptosis [19,20]. The occurrence of podocyte
apoptosis directly or indirectly has a correlation with the
activation of caspase3, and increased level of p53 in-
duces apoptosis [21,22].
In the present study, it was hypothesized that Angptl3
plays a potential role in the PAN-induced podocyte loss
by affecting detachment and apoptosis in vitro. Integrin
α3β1, ILK, p53 and caspase3 are molecules of interest
for further study to know the possible mechanism. How-
ever, the partial result obtained in the present study – re-
combinant Angptl3 protein aggravated the PAN-induced
podocyte detachment is contrary to the results of our pre-
vious study, i.e. ANGPTL3 gene transfection ameliorates
PAN-induced podocyte detachment [9].
Methods
Antibodies and reagents
The antibodies and reagents used in the present study are
listed with their sources in parentheses: mouse monoclo-
nal antibody (mAb) to glyceraldehyde-phosphate dehydro-
genase (GAPDH), rabbit polyclonal antibody to Angptl3,
integrin alpha 3, total integrin beta 1, phospho-integrin
beta 1 (phospho T789) and ILK; anti-active + pro- caspase
3 antibody (Abcam, Cambridge, UK); p53 mouse mAb
(Cell Signaling Technology, Beverly, USA); recombinant
mouse Angptl3 protein (rm-Angptl3) (R&D Systems,
Minneapolis, USA); PE Annexin V Apoptosis Detection
Kit I (BD Biosciences, San Diego, USA); In Situ Cell DeathDetection kit (Roche, Mannheim, Germany); and fluores-
cein-labelled phalloidin (Sigma Aldrich, St. Louis, USA).Cell-lines, culture, and treatment
The mouse podocytes used in this study were a condi-
tionally immortalized cell-line originated by Dr. Peter
Mundel (Massachusetts General Hospital, Boston, USA).
Culture procedures of the cells were performed accord-
ing to the standards outlined by Professor Mundel [23].
Briefly, the podocytes were cultured in RPMI 1640
medium containing 10% fetal bovine serum, 100 U/ml
penicillin, and 100 ug/ml streptomycin. Podocytes were
cultured in a medium containing 10 U/ml mouse inter-
feron-gamma (IFN-γ) at 33°C with 100% relative humidity
and a 5% CO2 in air atmosphere to enhance the expression
of a thermosensitive T antigen. To induce differentiation,
podocytes were grown under non-permissive condi-
tions at 37°C in the absence of IFN-γ for 14 days. At
that time, podocytes became large cells with numer-
ous small branches when well differentiated. All cell
culture dishes were coated with type I collagen (Sigma-
Aldrich). Podocytes were treated with Angptl3 pro-
teins at various doses (50,100,200,250 and 500 ng/ml)
for 24 hours, and with Angptl3 proteins (500 ng/ml)
for 0, 3, 6, 9, 12, 24, 36 and 48 hours, either alone or
after PAN (50 μg/ml, 10 hours) pretreatment. Doses
of Angptl3 proteins and times were determined according
to our previously reported data [11,24]. All experiments
were repeated at least three times.Treatment of podocytes with siRNA
Podocytes cultured in six-well plates were incubated
with 100 pmol siRNA for 30 hours using Lipofecta-
mine® 2000 (lip2000) Transfection Reagent (Invitrogen,
Carlsbad, USA) for transient transfection according to the
manufacturer’s protocol of lip2000. Podocytes were 30–
50% confluent at the time of transfection. Angptl3-specfic
siRNA (Angptl3 siRNA) that was used to silence Angptl3
as well as the control siRNA was designed and produced
by Invitrogen. The negative control carboxy-fluorescein -
labeled siRNA was used in pilot experiments to determine
the optimal transfection rates. The sequences of siRNAs
are shown in Table 1.
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Western blotting was performed according to the stand-
ard procedures. An equal amount of each protein lysate
was loaded onto 8% or 10% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis gels and blotted onto
polyvinylidene fluoride membranes. Samples were blocked
in Tris-buffered saline Tween 20 (20 mM Tris-HCl, pH 7.4
and 0.05% Tween 20) with 5% non-fat dry milk. The
membranes were incubated with primary antibodies at
appropriate dilutions overnight at 4°C and horseradish
peroxidase-linked secondary antibody (at a dilution of
1:2000) (Santa Cruz, USA) for 1 hour at room tempe-
rature. The results were visualized by fluorography
using the Tanon gel imaging system (Tanon, Shanghai,
China).
Enzyme linked-immunosorbent assay
After treatment, cell culture supernatant was collected and
centrifuged at 1000 g for 20 min to remove particulates
and assayed for Angptl3 protein secreted by podocytes by
the ANGPTL3 (mouse) enzyme-linked immunosorbent
assay (ELISA) Kit (AdipoGen, Liestal, Switzerland) accord-
ing to the manufacturer’s protocol.
F-action immunoflurorescence staining
Cells were washed twice with PBS and fixed in 4% para-
formaldehyde in PBS for 20 min at room temperature.
After the cells were washed three times with PBS, the
non-specific binding sites were blocked for 45 min with
3% bovine serum albumin at room temperature before
being incubated with fluorescein-labeled phalloidin over-
night at 4°C. Nuclei were stained with 4′6′-diamidino-2-
phenylindole dihydrochloride (DAPI) for 20 min at room
temperature. Images were obtained using an LSM 710 laser
scanning confocal microscope (Carl Zeiss, Thornwood,
USA). The percentage of stress fibers and mean fluores-
cence intensity (MFI) of F-actin under confocal microscopy
were analyzed as per our previous study by Liu et al. [25];
lamellopodia was quantified as per our previous study by
Lin et al. [11]; at least 100 randomly chosen cells were
analyzed.
Detachment assay
The detachment of podocytes was assayed according to
our previous study [9]. All cells were cultured on six-well
plates under nonpermissive conditions for 14 days prior
to the experiments, fields of cells were marked, and cell
numbers per field were counted to establish a baseline
number. The mean numbers of different fields in three in-
dependent sets in this experiment were determined.
Detection of apoptosis
Both PE-Annexin-V detection of apoptosis and deoxynu-
cleotidyl transferase-mediated dUTP nick-end labeling(TUNEL) assay were used to detect apoptosis. Methods
were performed using PE-Annexin-V Apoptosis Detection
Kit (BD Biosciences) and In Situ Cell Death Detection kit
(Roche) following the manufacturer’s protocol. Overall,
6000 cells per experiment were resuspended with PE-
Annexin-V and 7-aminoactinomycin D and analyzed using
flow cytometry. TUNEL staining was examined under
fluorescence microscope (Olympus, Japan), for each group
in given experiments, at least 300 randomly chosen cells
were determined for the quantification.
Statistical analysis
All experiments were repeated at least three times. Data
were expressed as mean ± standard deviation. Cell detach-
ment assay was performed by Student’s t-test or one-way
analysis of variance followed by the Student Newman-
Keuls post hoc test, with P-values <0.05 considered statis-
tically significant.
Results
Angptl3 affected the PAN-induced podocyte detachment
The effect of Angptl3 on tpodocyte detachment was
evaluated in podocytes treated with exogenous rm-
Angptl3 and Angptl3 siRNA. There was no significant
difference in the rate of attached cells in podocytes
treated with different doses of rm-Angptl3 alone during
24 hours. However, a significant difference was noted in
the the rate of attached cells of podocytes which treated
with rm-Angptl3 (100-500 ng/ml, 24 h) in combination
with PAN pretreatment. The rm-Angptl3 markedly ac-
celerated the PAN-induced podocyte detachment, and in
a dose-dependent manner (Figure 1a). It was also found
that rm-Angptl3 (500 ng/ml) initiated the aggravation of
PAN-induced detachment of podocyte at 9 h, and reached
a maximum at 24 h (Figure 1b).
Angptl3 siRNA was used to inhibit the expression of
Angptl3 in podocytes. Compared to control siRNA,
Angptl3 siRNA resulted in a highly significant reduction
in the expression and secretion of Angptl3 protein
(Figure 1c and d). The knockdown of Angptl3 by Angptl3
siRNA rarely influenced the detachment of podocytes
under normal conditions, while Angptl3 siRNA markedly
rescued the detachment of podocytes induced by PAN
(Figure 1e).
Apoptosis almost occurred simultaneously with
detachment in Angptl3-influenced podocyte loss
Podocyte apoptosis was detected simultaneously with
detachment assay under the same experimental condi-
tions. The flow cytometry analysis and TUNEL assay
showed that rm-Angptl3 or Angptl3 siRNA alone could
not induce the apoptosis of podocytes under normal
conditions (Figure 2). The rate of apoptosis detected
by flow cytometry in the podocytes with rm-Angptl3
Figure 1 Angptl3 affected the PAN-induced podocyte detachment. (a) The detachment was determined in the podocytes at different doses
(50,100,200,250 and 500 ng/ml) of rm-Angptl3 with or without PAN (50 μg/ml, 10 hrs) pretreatment for 24 hrs, it shown that rm-Angptl3 without
PAN could not change the attached cells in normal podocytes significantly, while, in podocytes pretreated with PAN, rm-Angptl3 reduced the
attached cells markedly, and the more the doses (100-500 ng/ml), the less the attached cells. (b) The rates of attached cells podocytes treated
with rm-Angptl3 for different times after PAN pretreatment; the cells decreased from 9 h to 48 h, and the rate of 24 h was the lowest. (c) ELISA
results showing weaker secretion of Angptl3 in the medium of Angptl3 siRNA group (lowered by 69.50%); (d) Western blot confirmed that
Angptl3 was knocked down by siRNA successfully (reduced by 86.89 ± 3.58%). (e) There was no statistical difference between cell number in the
Wt group and control siRNA group with or without PAN pretreatment. Cell number in the control siRNA group and Angptl3 siRNA group were
almost the same, while, after PAN pretreatment, cell number in the Angptl3 siRNA group is more than in the control siRNA group. (Wt: wide type;
Control siRNA: podocytes transfected with control siRNA; Angptl3 siRNA: podocytes transfected with Angptl3 siRNA. *P <0.05, **P <0.01, ***P <0.0001)
Angptl3, angiopoietin-like3; ELISA, enzyme-linked immunosorbent assay; PAN, puromycin aminonucleoside; siRNA, small interfering RNA.
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higher than that in podocytes treated with PAN
alone. When the podocytes were pretreated with
PAN, the rate of apoptosis in the Angptl3 siRNA
group was a little lower than that in the control siRNA
group (Figure 2a). A similar finding was obtained
using the TUNEL assay for apoptosis in cultured podo-
cytes (Figure 2b and c).
F-actin rearrangement was involved in
Angptl3-influenced podocyte loss
Angptl3 influenced the detachment and apoptosis in
the PAN-induced podocyte loss. To further investi-
gate whether F-actin rearrangement is involved in theobserved process, fluorescent phalloidin-labeled F-actin
was used to observe actin cytoskeletal rearrangement in
podocytes. As shown in Figure 3, podocytes treated with
rm-Angptl3 formed more spikes and lamellipodia com-
pared to the transversal F-actin location in control
podocytes. There were no significant differences in the
F-actin staining pattern between podocytes transfected
with Angptl3 siRNA and control siRNA. When the
podocytes were pretreated with PAN, the disruption of
F-actin filament was found to be more severe in podotyes
treated with rm-Angptl3 compared to the podocytes with-
out treatment with rm-Angptl3, while the Angptl3 siRNA
ameliorated the PAN-induced disruption of F-actin fila-
ment (Figure 3a).
Figure 2 Angptl3 affected apoptosis in PAN-induced podocyte injury model. (a) Flow cytometry analysis of the rate of apoptosis in the
cultured podocytes with different treatments. No significant differences in the number of apoptotic cells were observed among control,
rm-Angptl3, control siRNA and Angptl3 siRNA groups. After PAN pretreatment, the rate of apoptosis was significantly increased in the rm-Angptl3
group compared to the control group (34.80±7.9 vs. 1.89±0.92 3%, P<0.0001; n=6). And in comparison to the control siRNA group, apoptosis rate
in the podocytes treated with Angptl3 siRNA was a little lower (9.29±1.27vs. 17.42±2.61%, P<0.05; n=6). (b, c) This finding was confirmed using
TUNEL assay for apoptosis in cultured podocytes. In PAN-induced podocyte injury model, TUNEL positive cells in rm-Angptl3-treating group are
significantly more than that without rm-Angptl3 treating (56±9 vs. 8±10 %, P<0.0001; n=6), and TUNEL positive cells in the Angptl3 siRNA group
are significantly less than that in control siRNA group (32±4 vs. 54±9 %, P<0.05; n=6) (magnification ×400). (Control: podocytes treated without
rm-ANGPTL3; Rm-ANGPTL3: podocytes treated with rm-ANGPTL3. *P<0.05, ***P<0.0001). Angptl3, angiopoietin-like3; PAN, puromycin aminonucleoside;
siRNA, small interfering RNA; TUNEL. deoxynucleotidyl transferase-mediated dUTP nick-end labeling.
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demonstrated that rm-Angptl3 in combination with
PAN pretreatment significantly disrupted stress fiber,
while, administration of PAN failed to decrease stressfiber contents in the Angptl3 knockdown podocytes
(Figure 3b). The MFI of F-actin further showed that
Angptl3 siRNA alleviated the reduction in MFI induced
by PAN (Figure 3c).
Figure 3 Angptl3 influenced the F-actin rearrangement in podocytes. (a) Phalloidin fluorescence labelling of F-actin showed podocyte stress
fibers. Confocal microscopy showed no difference in the F-actin staining pattern between control group and Angptl3 siRNA group. However,
F-actin rearrangement in Angptl3 group, characterized by the formation of lamellipodia (arrowhead) and increase in cell spikes (arrow). In PAN
induced podocyte injury model,cells became retracted and F-actin seemed partial disrupted,moreover, F-actin almost completely disrupted in
Angptl3 protein group. However, disruption did not occur in Angptl3 knockdown group. (b) The percentage of stress fibers also showed that
Angptl3 protein could significantly aggravate the effect of PAN on decreaseing podocyte stress fibers while Angptl3 siRNA could prevent PAN
from decreasing podocyte stress fibers. (c) Quantitative analysis showed the MFI of F-actin in different groups under confocal microscopy. After
PAN treatment, MFI value in the Angptl3 siRNA group is higher than in the control siRNA group. (Scale bar, 5 μm *P <0.05, **P <0.01. n=100).
Angptl3, angiopoietin-like3; MFI, mean fluorescence intensity; PAN, puromycin-aminonucleoside; siRNA, small interfering RNA.
Dai et al. BMC Nephrology  (2015) 16:38 Page 6 of 10Integrin α3β1, ILK, and p53, rather than caspase 3, are
necessary for Angptl3 to affect the PAN-induced
podocyte loss
To elucidate the possible molecular mechanism of
Angptl3 on PAN-induced podocyte loss, the expression
of integrin α3, total integrin β1, phospho-integrin β1,
ILK, p53, and caspase 3 was examined in cultured podo-
cytes with various treatments.
Western blots confirmed lower expression of integ-
rinβ1 and overexpression of phospho-integrin β1and
ILK in the PAN induced podocyte injury model in vitro
[18,20]. Angptl3 could not alter the expression of in-
tegrin α3, total integrin β1, phospho-integrin β1, and
ILK in podocytes under normal conditions. However,
rm-Angptl3 and Angptl3 siRNA displayed remarkablechanges in the levels of integrin α3, total integrin β1,
phospho-integrin β1 and ILK in podocytes with PAN
pretreatment: rm-Angptl3 weakened the expression of
integrin α3β1 and strengthened the phospho-integrin
β1 and ILK; on the contrary, the knockdown of Angptl3 by
siRNA prevented weakening of integrin α3β1, and enhance-
ment of ILK in PAN-induced podocyte detachment, but no
difference in the levels of phospho-integrin β1 between
the Angptl3 siRNA and control groups (Figure 4a-e). Rm-
Angptl3 combined with PAN markedly increased p53 pro-
tein levels, while, in PAN-induced podocyte injury model,
p53 protein levels in the Angptl3 siRNA group was a little
lower than that in the control siRNA group. No increased
activation of caspase 3 was observed in any groups of
podocytes in the present study (Figure 4f-g).
Figure 4 Angptl3 orchestrated integrin α3β1, ILK and p53, rather than caspase 3 in podocytes on treatment with PAN. (a) Western blots
were performed on the expression of integrin α3, total integrin β1, phospho-integrinβ1, and ILK in podocytes with different treatment, it was
showed that, there was no significant difference of in the observed molecular expression in podocytes without PAN pretreatment, while, after
treatment with PAN, expression of integrin α3 and total integrin β1 became lower (ILK and phospho- integrin β1, higher) in the rm-Angptl3
group than that in the control group, and Angptl3 siRNA group showed higher expression of integrin α3, total integrin β1 (ILK, lower) than in
control siRNA group, while, phospho- integrinβ1 in the two group had no statistical difference. (b, c, d, e) Relative levels of integrin α3, total
integrin β1, phospho- integrinβ1 and ILK. (f, g) Western blots suggesting that there was rarely no activated caspase 3 in any observed groups;
with PAN pretreatment, p53 protein level was markedly increased in rm-Angptl3 group with comparison to the control group, while, p53 protein
level in Angptl3 siRNA group was a little lower than that in the control siRNA group, no p53 protein was detected in any other groups. (*P<0.05,
**P<0.01, ***P<0.0001 n=6). Angptl3, angiopoietin-like3; ILK, integrin-linked kinase; PAN, puromycin aminonucleoside; siRNA, small interfering RNA.
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Progressive glomerulosclerosis accounts for the vast
majority of chronic kidney disease leading to end-
stage renal disease [26]. Ongoing podocyte loss con-
tributes to the progression of glomerulosclerosis andproteinuria, as podocytes cannot be replaced easily
[2,27]. PAN model is one of the best described models
of podocyte injury, which could induce cytoskeletal dis-
aggregation, detachment and apoptosis in podocytes
[16,28,29].
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a vital role in the PAN-induced podocyte loss, both
detachment and apoptosis occurred, and F-actin re-
arrangement was involved in the process of Angptl3-
influenced podocyte loss.
It was found that rm-Angptl3 could not induce the
detachment of podocytes under normal conditions.
Interestingly, in the PAN-induced podocyte injury model,
rm-Angptl3 aggravated the detachment, and the knock-
down of Angptl3 served to rescue detachment. Curiously,
this partial finding in the present study – rm-Angptl3
aggravated the PAN-induced podocyte detachment was in
contrast to our previous study by Rao et al. – ANGPTL3
gene transfection ameliorates the PAN-induced podocyte
detachment [9]. The experimental methods and condi-
tions in the two studies were different: in the former
study, recombinant Angptl3 protein was used to treat
podocytes to mimic the conditions of Angptl3 overexpres-
sion, most of the Angptl3 protein found in the culture
medium was derived from the exogenous recombinant
Angptl3 protein, weakly secreted by podocytes; in the lat-
ter study, recombinant plasmid pcDNA3.1-ANGPTL3
was transfected into podocytes with lip2000 reagent to
promote the overexpression of Angptl3, the Angptl3 pro-
tein presented in culture medium was all secreted by
podocytes. Angptl3 is a secreted glycoprotein, Ge et al.
performed that Angptl3 can form higher-order structures
[30], and Ryuta, et al. suggested deglycosylation reduces
the apparent molecular mass of the secreted recombinant
Angptl3 (70kD) to 53 kD [31]. We detected the podocyte
Angptl3 proteins and the exogenous recombinant Angptl3
proteins by western blotting with anti- Angptl3 polyclonal
antibody, both protein bands of approximately 70kD and
53kD appeared in the podocytes Angptl3 proteins, while,
only protein band of 70kD (no 53kD protein band) ap-
peared in the recombinant Angptl3 proteins (data not
shown). We therefore suggest that the podocyte-specific
Angptl3 and the exogenous recombinant Angptl3 might
have different protein modifications and/or structures.
Clement et al. found podocyte-specific Angptl4 and circu-
lating Angptl4 might play different roles in proteinuria
[32,33]. Angptl3 is a homolog of Angptl4 [30]. Hence it
was speculated that the different experimental methods
and conditions might partially influence the contrasting
results; moreover, much of the contrasting results is likely
due to the differential roles the podocyte-specific Angptl3
and the exogenous Angptl3 proteins played in podocyte
detachment, and the differential roles might result from
the different protein modifications and/or structures. The
contradictory results indicate that exogenous recombinant
Angptl3 proteins may be a damaging factor in PAN-
induced podocyte detachment, while, podocyte-specific
Angptl3 may provide a protective role to some extent
under abnormal states. However, direct evidence islacking, further studies are needed to confirm the present
results.
Apoptosis is one of the key factors in determining the
number of podocytes in the glomeruli [3]. And it was
found in this study that rm-Angptl3 combined with
PAN could induce podocyte apoptosis, while the knock-
down of Angptl3 ameliorated apoptosis of podocytes
with PAN pretreatment. So we concluded that Angptl3
affected apoptosis almost simultaneously with detach-
ment in PAN-induced podocyte injury model, both de-
tachment and apoptosis occurred in Angptl3-influenced
podocyte loss.
Using confocal microscopy to assess the rearrange-
ment of F-actin in podocyte under the same experimen-
tal conditions in our present study, it was confirmed
that Angptl3 induces the rearrangement of actin fila-
ment in podocytes, which is consistent with our previous
observation [13]. Moreover, knockdown of Angptl3 by
siRNA failed to change F-actin filament, which may
indicate that Angptl3 is not a necessary conditional mol-
ecule in maintaining the intricate shape and structure of
podocytes. Rm-Angptl3 combined with PAN pretreat-
ment disrupted F-actin filament, knockdown of Angptl3
attenuated the rearrangement of F-actin induced by
PAN. It was confirmed that F-actin rearrangement was
involved in the process of Angptl3-influenced podocyte
loss. The results of the present study indicated that
decrease or disruption of podocytes stress fibers may
aggravate the loss of podocytes.
Second, the present study pointed to the possible
molecular mechanism of the observed effects of Angptl3.
Both integrin α3β1 and ILK are key molecules in podo-
cyte detachment, ILK is in its inactive state under nor-
mal resting conditions, PAN-induced podocyte damage
could activate ILK, and active ILK can phosphorylate the
cytoplasmic domain of β1-integrin, which results in a
low-affinity binding state and podocytes are detached
from the GBM[15-18]. It is likely that the combined
action of both integrin α3β1 and ILK accounts for the
effects of Angptl3 on PAN-induced podocyte detachment,
which were partially correlated with Angptl3 could affect
the influence of PAN on altering the expression of integrin
α3, total integrinβ1, phosphorylation of integrin β1 and
ILK. Angptl3 may affect the PAN-induced detachment via
ILK/integrin α3β1 pathway, detection of the activity of
ILK and observation of the results after inhibiting ILK,
which would provide much more information.
Changes in activated caspase 3 and increased levels of
p53 are often observed in podocyte apoptosis [21]. In
the present study, it was found that the increased p53
was positively correlated with the increased apoptosis,
while activated caspase 3 was rarely observed. Mohr,
et al. found that not all apoptosis requires caspase-3 ac-
tivation [34], so we speculated that the alterations of p53
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uted to the influence of ANGPTL3 on apoptosis in the
present study. Taken together, the effects of Angptl3
may be more complex than currently understood, and
the exact mechanism needs to be further studied.
Conclusion
Angptl3 is a novel factor involved in PAN-induced
podocyte loss by affecting detachment and apoptosis.
The present study might be helpful in understanding the
mechanisms of podocyte loss, and in developing a new
successful therapy for podocyte injury via lower expres-
sion of Angptl3.
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